Committed under
Bioprovar Corporation
$1.3 Million committed in all years on record · 0.0% of the program
- Full records
- Bioprovar Corporation → everything they’re paid, across every program and agencyAging Research → the whole program, every recipientDepartment of Health and Human Services → everything they pay out
By fiscal year
Aging Research dollars committed to Bioprovar Corporation, per fiscal year.
* FY2026 is year-to-date — the fiscal year is still in progress, so its total is still filling in. The striped band and dashed line mark that provisional stretch.
Awards
The largest awards to Bioprovar Corporation under this program.
An Innovative Immune Therapy With Antibiotics to Treat Deadly Excess Inflammation in Sepsis and Ards Induced From Severe Bacterial Infection…
Jun 16, 2026$860,725
An Innovative Immune Therapy Targeting the TREM1-INFLAMMATION Pathway to Alleviate Excess Inflammation in Ulcerative Colitis of Geriatric Pa…
How to read these numbers
- Just these two
Every figure is money committed to this recipient under this one program — nothing they get anywhere else, from this program or any other.
- Totals by action year
The aggregates reflect the fiscal year picked at the top, counted in the year each action happened.
- “Active in FY X”
The award list shows every award between the two with an action that year, at its full lifetime value — so a single award's amount can top that year's committed total.
- From FY2018 on
Pairing pages start at fiscal year 2018, the first year of complete assistance reporting.
- The colored bars
Every bar on this page splits by how the money moves:
Direct paymentsGrants